Category Specific RSS

Samantha Freidin

Resonating with investors – digital health company looking to turn themselves around

Following months of a steadily downtrending share price, things seem to be looking up for digital health company Resonance Health…

5 years ago

Dosing commenced in Phase 2 trial for Pharmaxis’ lead asset myelofibrosis drug

With a share price that has effectively doubled over the past few months and a drug pipeline beginning to snowball…

5 years ago

Goodbye lounge room gym! Viva Leisure expands portfolio just in time for lockdown lift

If you’re like me you’re probably a bit over using your lounge room as an office, cinema, dining room and…

5 years ago

ResApp expands their diagnostic offering into disease affecting 1 billion worldwide

Experts estimate that sleep apnoea affects nearly 1 billion people worldwide. Every year, 4 million people die prematurely from chronic…

5 years ago

Contraceptive alternatives – Mayne Pharma receives FDA response putting them a step closer to approval

Of the myriad of contraceptives out there, those that don’t require daily effort are gaining in popularity. As our lives…

5 years ago

Race Oncology gains more patents for their cancer drug, Zantrene

The field of cancer research is certainly buzzing with key research yielding new medications with the ultimate goal of improving…

5 years ago